France Digital Therapeutics Market Insight
Published: 28 September 2026 | Report Format: Electronic (PDF) | Author: Komal and Radhika
The market for France Digital Therapeutics is expected to see an increase in growth at a CAGR of 26.15%, which is caused by the increasing incidence of chronic diseases, utilization of artificial intelligence-based digital therapeutics, supportive reimbursement regulations, and use of software therapeutics
France Digital Therapeutics Market Insights Forecasts to 2035
- The France Digital Therapeutics Market Size Was Estimated USD 313.6 Million in 2025
- The Market Size is Expected to Grow at a CAGR of around 26.15% from 2025 to 2035
- The France Digital Therapeutics Market Size is Expected to rise around USD 3200.4 Million by 2035
Notable Insights for the France Digital Therapeutics Market
- The application-based segmentation suggests that the Diabetes segment has a strong market share in the France Digital Therapeutics Market owing to the increase in diabetic patients and usage of digital disease management platform.
- End-user based segmentation indicates that health systems and providers lead in terms of adoption of digital therapeutics because of the presence of the same in chronic disease management as well as remote patient monitoring processes.
- Global revenue of Teladoc Health, Inc. was above $2.6 billion in 2025 fiscal year, due to the need for virtual care solutions, chronic disease management solutions and software-based therapy solutions.
- As predicted, growth in the market will be driven by the increasing deployment of artificial intelligence technologies, funding, and development of digital health solutions.
Download the eBook (ToC)
Research Methodologies Used to Analyze the France Digital Therapeutics Market
The France digital therapeutics market is analyzed by a blend of primary and secondary research approaches for ensuring accurate information about the market and its forecasted performance. Primary research is conducted through discussions with digital health platform providers, healthcare organizations, software developers, hospitals, regulatory specialists, and industry experts to analyze demand trends, technological progress, and competitive activities. Secondary research will involve analyzing reports published by companies and governments, healthcare journals, scientific papers, reimbursement frameworks, digital health databases, and industry organizations associated with healthcare technology and therapeutics sectors. Market estimation, trend analysis, and forecasting methods will be used for estimating market size, growth opportunities, adoption patterns, pricing dynamics, and investments.
Decisions Advisors Research Methodology: Trusted Insights for Strategic Decision-Making
What is Decisions Advisors Research?
Decisions Advisors research delivers comprehensive market intelligence through detailed industry analysis, competitive benchmarking, trend forecasting, and data-driven business insights. Our research methodology combines advanced analytical frameworks with extensive primary and secondary research to help organizations make informed and strategic business decisions.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the France Digital Therapeutics Market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in France Digital Therapeutics Market
- Teladoc Health, Inc.
- DarioHealth Corp.
- Akili, Inc.
- ResMed Inc.
- BioGaia AB
- Wellthy Therapeutics Pvt. Ltd.
- Sidekick Health
- Kaia Health Software GmbH
- Omada Health, Inc.
- Hinge Health, Inc.
Recent Developments:
- In July 2026, Introduction of Teladoc One by Teladoc Health is a connected virtual care platform that combines AI-powered care coordination and multidisciplinary care team approach along with digital health care services for individuals to help achieve better health outcomes and manage chronic diseases.
- In July 2026, DarioHealth introduced the Integrated GLP-1 Program that integrates the company’s AI-driven digital chronic care solution with provider-supervised clinical care such as medical assessment and treatment prescription for the management of obesity and cardiometabolic diseases.
Market Segmentation:
France Digital Therapeutics Market, By Technology
- AI-Based Digital Therapeutics Platforms
- • Mobile Health Applications
- • Cloud-Based Therapeutic Solutions
- • Remote Patient Monitoring Systems
- • Data Analytics & Personalized Care Platforms
France Digital Therapeutics Market, By Application
- Diabetes
- Obesity Management
- Cardiovascular Diseases
- Respiratory Diseases
- Central Nervous System Disorders
France Digital Therapeutics Market, By End User
- Healthcare Providers
- Patients
- Payers & Insurance Organizations
- Employers
- Healthcare Systems
Expert Views:
The growth in the market for digital therapeutics in France will be aided by an increase in the prevalence of chronic diseases, favorable digital health policy, and increased need for personalization and remote care solutions. The implementation of AI-based therapeutic platforms, reimbursement-backed digital interventions, and patient management technologies will aid in enhancing adherence and efficiency in healthcare delivery while fostering increased demand in the French healthcare ecosystem.
Author: Komal and Radhika By Decisions Advisors and Consulting